"Keratolytic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases.
| Descriptor ID |
D007641
|
| MeSH Number(s) |
D27.505.954.444.400
|
| Concept/Terms |
Keratolytic Agents- Keratolytic Agents
- Agents, Keratolytic
- Skin-Peeling Agents
- Agents, Skin-Peeling
- Skin Peeling Agents
- Desquamating Agents
- Agents, Desquamating
|
Below are MeSH descriptors whose meaning is more general than "Keratolytic Agents".
Below are MeSH descriptors whose meaning is more specific than "Keratolytic Agents".
This graph shows the total number of publications written about "Keratolytic Agents" by people in this website by year, and whether "Keratolytic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 2 | 1 | 3 |
| 2014 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Keratolytic Agents" by people in Profiles.
-
Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma. J Cutan Pathol. 2020 Oct; 47(10):954-959.
-
Inherited Interleukin 2-Inducible T-Cell (ITK) Kinase Deficiency in Siblings With Epidermodysplasia Verruciformis and Hodgkin Lymphoma. Clin Infect Dis. 2019 05 17; 68(11):1938-1941.
-
Linear, pruritic red to brown papules on the left chest. Dermatol Online J. 2014 Nov 15; 20(11).
-
Pityriasis rubra pilaris: failure of combination treatment with acitretin and infliximab. Dermatol Online J. 2006 May 30; 12(4):18.
-
Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene. Proc Natl Acad Sci U S A. 1998 Dec 08; 95(25):14811-5.
-
Hidradenitis suppurativa. South Med J. 1998 Dec; 91(12):1107-14.
-
Pharmacokinetics and safety review of tazarotene. J Am Acad Dermatol. 1998 Oct; 39(4 Pt 2):S134-8.
-
The pathogenesis of psoriasis and the mechanism of action of tazarotene. J Am Acad Dermatol. 1998 Oct; 39(4 Pt 2):S129-33.
-
Steady-state pharmacokinetics of isotretinoin and its 4-oxo metabolite: implications for fetal safety. J Clin Pharmacol. 1998 Oct; 38(10):926-30.
-
Is topical tretinoin safe during the first trimester? Can Fam Physician. 1998 Mar; 44:495-8.